These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28535016)

  • 1. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
    Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
    Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
    Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
    Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
    Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
    Cirillo F; Spinelli A; Talia M; Scordamaglia D; Santolla MF; Grande F; Rizzuti B; Maggiolini M; Gérard C; Lappano R
    J Transl Med; 2024 May; 22(1):450. PubMed ID: 38741146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R; Emons G; Gründker C
    Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
    He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
    Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
    Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
    J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
    Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; Avino S; De Marco P; Bussolati B; Maggiolini M; De Francesco EM
    Oncotarget; 2016 Jan; 7(1):94-111. PubMed ID: 26646587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
    Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
    J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphenol A induces focal adhesions assembly and activation of FAK, Src and ERK2 via GPER in MDA-MB-231 breast cancer cells.
    Castillo-Sanchez R; Ramirez-Ricardo J; Martinez-Baeza E; Cortes-Reynosa P; Candanedo-Gonzales F; Gomez R; Salazar EP
    Toxicol In Vitro; 2020 Aug; 66():104871. PubMed ID: 32325111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
    Tao S; He H; Chen Q; Yue W
    Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-Protein Coupled Estrogen Receptor in Breast Cancer.
    Hsu LH; Chu NM; Lin YF; Kao SH
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.
    Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
    Girgert R; Emons G; Gründker C
    BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.